Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01447914 · COMPLETED
Trial details
- NCT number
- NCT01447914
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.